CLINICAL_TRIALS
trial_result
· 2023-02-14
Clinical Trial Update: Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine [Phase 3]
Summary
Phase 3 trial update on atogepant for prevention of chronic migraine, reporting efficacy, safety, and tolerability results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Chronic Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-02-14